- Home
- MDGL vs CR Comparison
MDGL vs CR Comparison
Compare MDGL & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | CR |
|---|---|---|
| Founded | 2011 | 1855 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 11.9B |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MDGL | CR |
|---|---|---|
| Price | $542.61 | $202.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $674.45 | $226.20 |
| AVG Volume (30 Days) | 246.5K | ★ 342.6K |
| Earning Date | 05-06-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | N/A | ★ 23.96 |
| EPS | N/A | ★ 2.78 |
| Revenue | $180,133,000.00 | ★ $2,305,000,000.00 |
| Revenue This Year | $58.39 | $27.98 |
| Revenue Next Year | $48.55 | $5.76 |
| P/E Ratio | ★ N/A | $71.68 |
| Revenue Growth | N/A | ★ 8.16 |
| 52 Week Low | $393.61 | $159.58 |
| 52 Week High | $615.00 | $230.50 |
Technical Indicators
Market Signals| Indicator | MDGL | CR |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 36.09 |
| Support Level | $529.02 | $183.02 |
| Resistance Level | $545.13 | $227.23 |
| Average True Range (ATR) | 17.76 | 5.90 |
| MACD | 2.63 | -1.32 |
| Stochastic Oscillator | 78.60 | 15.21 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and advanced technologies, and process flow technologies. Crane generated approximately $2.3 billion in revenue in 2025.